Bangalore, India -- (SBWire) -- 05/08/2018 --Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018" provides an overview of Transdermal Drug Delivery currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by Publisher's team of industry experts.
Scope
- Extensive coverage of the Transdermal Drug Delivery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transdermal Drug Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Transdermal Drug Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Spanning over 529 pages "Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018" report covers Introduction, Products under Development, Transdermal Drug Delivery - Pipeline Products under Development by Companies, Transdermal Drug Delivery Companies and Product Overview, Transdermal Drug Delivery- Recent Developments, Appendix. This report Covered Companies few are - Apricus Biosciences Inc, Asahi Kasei Pharma Corp, AstraZeneca Plc, Avro Life Sciences, Burke Pharmaceuticals LLC, CB Scientific Inc., Cerimon Pharmaceuticals, Inc., Chrono Therapeutics Inc, Corium International Inc, DBV Technologies SA, DD Therapeutics LLC, Dermisonics Inc, Dharma Therapeutics, Inc., Drexel University.
For more information Visit at: https://www.drugpipeline.net/globaldata/transdermal-drug-delivery-medical-devices-pipeline-assessment-2018
Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare
Related Reports;
BRIC Nasal Splints Market Outlook to 2025 - Visit at - https://www.drugpipeline.net/globaldata/bric-nasal-splints-market-outlook-2025
Asia-Pacific Speech Aid Devices Market Outlook to 2025 - Visit at - https://www.drugpipeline.net/globaldata/asia-pacific-speech-aid-devices-market-outlook-2025
About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.
Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018; New Report Launched
DrugPipeline.net has announced the addition of “Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018” research report to their website www.DrugPipeline.net